A cell responds to a chemotactic signal by activating actin polymerization and forming a protrusion oriented towards the source. Recent work shows that the activity of cofilin, a protein that creates new barbed ends for actin filament elongation, amplifies and specifies the direction of the response in carcinoma cells.
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Chemotaxis is the response of a cell to an extracellular diffusible or matrix-bound chemical signal that results in movement towards or away from the chemical, up or down a gradient. The signal molecule binds to a cell-surface receptor and the information is translated and amplified to stimulate local, directionally specific movement. While the signals and pathways for transmitting the information vary, in eukaryotes the actin cytoskeleton carries out the directional movement of the cell, via effects on actin polymerization and actin-myosin interactions.
Fundamental biological processes, including gastrulation, migration of neurons during the establishment of the nervous system in development, immune responses, wound healing, and cancer cell migration during metastasis, depend on chemotaxis [1, 2] . The mechanisms of chemotaxis have been intensively investigated in Dictyostelium, the social amoeba that responds to cyclic AMP when it becomes aggregation competent [3] . The other classic system for the study of chemotaxis is neutrophils, which respond to small peptides, such as fMLP produced by bacteria, and migrate to sites of infection where they phagocytose the bacteria [4] . Much has been learned about the pathways in Dictyostelium and neutrophils that lead to redistribution of signaling and cytoskeletal proteins and activation of the actin cytoskeleton resulting in polarization and directional migration [1, 2] . Following stimulation, the leading edge of the cell is driven forward by actin polymerization on new, fast-growing filament ends created by cofilin and nucleation of branches by the Arp2/3 complex, as well as elongation promoted by Ena/Vasp and formin families of proteins. The rear of the cell then follows via actin-myosin-mediated contraction.
A remaining question is, how are proteins in the signaling pathway that are abundant and widely distributed in an inherently non-polar cell activated to result in migration in a precise direction, up or down a chemical gradient? To address the question requires the ability to manipulate the molecules in the pathway and to monitor the results in space and in time. Progress has been made in metastatic breast carcinoma cells that undergo chemotaxis in response to epidermal growth factor (EGF), a model for cancer metastasis [5] . These cells are large and flat compared with Dictyostelium amoebae and neutrophils, making it possible to quantify images at the cellular and subcellular levels. The response takes place in the order of minutes, versus seconds, allowing resolution of the kinetics of the stages of the response in conjunction with live-cell imaging analysis.
The chemotactic response is biphasic with two transients of actin polymerization controlled by different signaling mechanisms [6, 7] , though the signaling mechanisms are cell-type specific. In carcinoma cells, the first phase, within one minute after EGF stimulation, requires activation of cofilin via phospholipase C (PLC) that, together with the Arp2/3 complex, results in formation of a dendritic array of new actin filaments that leads to protrusion of a lamellipodium [8, 9] . The second transient of barbed-end actin polymerization, three minutes after stimulation and regulated by phosphatidylinositol-3 kinase (PI 3-kinase), is required for motility but not protrusion [10] . Suppression of PLC or cofilin activity inhibits the sensing of the EGF gradient by the cells and leads to inhibition of the initial response, showing that cofilin is the key molecule for activation of the first transient of actin polymerization.
A paper in a recent issue of Current Biology joins a series of elegant studies from the Condeelis lab to unravel the mechanism of the chemotactic response in carcinoma cells. In this work, Mouneimne and colleagues [11] dissected the spatial and temporal regulation of cofilin activity. Cofilin, a protein that can create new barbed ends that serve to nucleate rapid actin polymerization [12] , is regulated in at least two ways. The most well-known regulator is LIM kinase-1, which phosphorylates cofilin, leading to its inactivation. PLC may also regulate cofilin by hydrolyzing bound phosphatidylinositol (4, 5) bisphosphate (PIP 2 ): given that PIP 2 inhibits the binding of cofilin to actin in vitro [13] , hydrolysis may result in cofilin activation. Before EGF activation, most of the cofilin in the cell is inactive, even though it is unphosphorylated, indicating a higher level of control, the details of which are not yet clear. After EGF stimulation, PLC activity increases, as does that of LIMK1, PLC's cofilin antagonist [9, 14] . Using a combination of methods to regulate selectively cofilin activity, previous work has shown that local activation of cofilin by PLC at the leading edge formed after EGF stimulation is required for directed protrusion, while phosphorylation by LIMK1 inactivates cofilin in the rest of the cell. The new work [11] combines spatial and temporal analyses of cells in which cofilin activity is regulated to show that Figure 1 . Diagram showing changes in the state and activity of cofilin, and its regulator, in a carcinoma cell in response to EGF. The colors represent idealized gradients of proteins and activities in an unstimulated, resting cell (top) and in a cell 60 seconds after stimulation by EGF locally released at the tip of a pipette (bottom). The color key applies to both panels. C is the centroid of the cell; F is the 'front' of the cell, the point of cellular protrusion in response to localized EGF release; B is the 'back' of the cell. The protrusion is drawn to be in line with the pipette tip and the centroid. The angle between this line and the pipette tip is used to calculate a 'chemotactic index' [11] . In the resting cell, even though the level of unphosphorylated cofilin is high, cofilin activity (measured in terms of actin filaments growing at the barbed ends) is low, as are the PLC activity and the levels of phosphorylated cofilin. After activation, there is local activation of PLC and global activation of LIMK, the kinase that phosphorylates cofilin. PLC activity and unphosphorylated cofilin follow the EGF gradient from the site of release, reflected in similar gradients of color saturation from the front to the back of the cell. By comparison, cofilin activity is amplified 11-fold compared to the EGF gradient, illustrated by a higher level of saturation at the site of protrusion and a steeper gradient away from the EGF source than is observed with PLC and unphosphorylated cofilin. Mouneimne and colleagues [11] carried out a series of experiments regulating the levels of cofilin and cofilin activity that indicated that local control of cofilin activity is important for amplification of the EGF signal and directional formation of protrusions. (Figure produced with the help of Vladimir Leontiev.) active cofilin is a key player in the amplification and directional specification of the chemotactic response in breast carcinoma cells. Together the work places cofilin in the driver's seat to control the localized production of the actin filaments that define directional protrusion, the first morphological manifestation of chemotaxis.
To arrive at this conclusion, the authors developed methods to create and quantify an EGF gradient, and the cell's response to the gradient. A gradient was created by releasing EGF at a pipette tip, and a decreasing gradient was calculated from that point (Figure 1) . The trajectory of the protrusion was measured and the angle of the protrusion relative to a line passing between the pipette tip and the centroid of the cell was used to calculate a 'chemotactic index'. The present studies revealed that cofilin is essential for directional sensing: suppression of cofilin with siRNA resulted in formation of protrusions in all directions, as did elevation of LIMK1 or overexpression of a constitutively active or inactive cofilin mutant, all pointing to the importance of local control of cofilin activity for directional formation of protrusions. The chemotactic index was measured in cells in which the levels and activities of cofilin, LIMK1 and PLC activity were individually regulated, in conjunction with the localization of the active forms of the proteins. The experiments that globally altered cofilin activity were complemented by specific immunostaining of cofilin, and its inactive, phosphorylated form. After activation, phosphocofilin increases at the front and back of the cell, whereas unphosphorylated cofilin preferentially accumulates at the protruding end of the cell, consistent with a role in protrusion formation. The global activation of LIMK1 was proposed to be crucial for preventing the spread of cofilin activation to other regions of the cell. Similarly, an antibody that recognizes the phosphorylated, active form of PLC was elevated at the front of the cell, leading to the suggestion that hydrolysis leads to the local release of PIP 2 and activation of cofilin. The gradients of cofilin and phosphorylated PLC after activation are comparable to the EGF gradient (Figure 1) . The functional readout of cofilin activity, that is, the creation of new barbed ends for actin filament polymerization, was also localized at the site of the protrusion, but in this case amplified 11-fold relative to the EGF gradient.
This latest advance in our understanding of how a rapid local response is mounted on the part of globally expressed molecules will undoubtedly have sequels. As Sydney Brenner once told a class of students, one of whom was me, ''The most important thing is to know what experiment you will do tomorrow!''. There is no shortage of good questions, just of clear answers. For example, how do the inactivation of cofilin by LIMK1 and activation of cofilin by PLC compete with each other? How is cofilin locally protected from phosphorylation if LIMK1 is globally active? Are slingshot phosphatases (that dephosphorylate cofilin) and 14-3-3zeta (a protein that binds to and stabilizes phosphorylated cofilin) coordinated with LIMK1, as they are in other systems [15, 16] ? Is the cofilin outside the active region inhibited by both PLC and PIP 2 binding? Since it is already clear that not all chemotactic, directionally migrating cells follow the same path to the destination [1, 2, 12] , it would be worthwhile investigating other systems that are amenable to the elegant analyses that have been possible in the carcinoma cells.
